India Diclofenac Sodium Market to grow at a steady rate During the Forecast Period
Growing cases of arthritis
in the country is expected to drive the growth of India diclofenac sodium
market during the forecast period.
According
to TechSci Research report, “India Diclofenac Sodium Market By Product Type
(Prescription v/s OTC), By Form (Tablet, Injection, Gel, Others), By
Application (Osteoarthritis, Ankylosing Spondylitis, Dysmenorrhea, Rheumatoid
arthritis, Migraine, Pain and Others), By Route of Administration (Oral,
Intravenous, Topical, Others), By Source (In-house v/s Contract Manufacturing
Organizations), By Distribution Channel (Online v/s Offline), By End User
(Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities,
FY2026”, the India diclofenac sodium market
is expected to grow at a steady rate during the forecast period on account of growing
prevalence of arthritis. Also, rising incidence of autoimmune diseases in the
country is creating growth opportunities for diclofenac sodium market over the
forecast period. Continuous growth in research and developmental activities is projected
to fuel the market growth through FY2026. Government initiatives and favorable
policies is further expected to positively contribute to the market growth in
the forthcoming years. Furthermore, growing awareness about anti-inflammatory
therapeutics is making headway for the growth of India diclofenac sodium market
in the years to come. However, there are certain factors that might act as
major impediments to the growth of India diclofenac sodium market during the
forecast period such as side effects of anti-inflammatory drugs and patent
expiry issues of drugs. Mounting demand for novel anti-inflammatory
therapeutics having lesser side effects coupled with better efficacy are estimated
to bode well for market growth in the years to come.
Browse XX market data Tables and XX
Figures spread through XXX
Pages and an in-depth TOC on" India
Diclofenac Sodium Market"
https://www.techsciresearch.com/report/india-diclofenac-sodium-market/7197.html
The India diclofenac sodium market is segmented based on product type, type, source, form,
distribution channel, application, route of administration,
company, and region. Based on distribution channel, the market can be
fragmented into online v/s offline. The offline channel is expected to dominate
the market which is attributable to the fact that consumers prefer buying
medicines from a pharmacy or drug store located nearby. The online segment is
also expected to register significant growth over the next few years. This can
be ascribed to the emergence of several online pharmacies and doorstep drug
delivery e-commerce platforms in the country.
Novartis India Ltd, Hetero Drugs
Ltd., Auro Laboratories Ltd., Aarti Drugs Ltd., J B Chemicals and Pharmaceuticals
Ltd., Novartis India Ltd., Emkay Pharma Pvt. Ltd., Bestochem Formulations (India) Limited, Salvavidas
Pharmaceutical Pvt. Ltd., Wellona Pharma Pvt. Ltd, and others are
some of the leading players operating in India diclofenac sodium market. The key market players operating in the market are using
organic strategies such as product launches, mergers and acquisitions, research
collaborations, joint ventures to boost their market share and to expand their
geographic reach. Along with this, supportive policy for the pharmaceutical
industry is anticipated to aid the current market of diclofenac sodium.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7197
Customers can also request for 10% free customization on
this report.
“India diclofenac sodium market is
expected to witness steady growth in the coming years on account of rising disorders
of the musculo-skeletal system amongst population. During all stages of pain
treatment, this drug is usually used in combination with sedatives,
antidepressants, and anti-epileptics as diclofenac sodium is most commonly used
painkiller. Also, continuous innovation in the field of diclofenac sodium drugs
for treating inflammatory pain is another key factor which is expected to
create lucrative opportunities for the market growth over the next five years.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based India management consulting firm.
“India Diclofenac Sodium Market By Product Type
(Prescription v/s OTC), By Form (Tablet, Injection, Gel, Others), By
Application (Osteoarthritis, Ankylosing Spondylitis, Dysmenorrhea, Rheumatoid
arthritis, Migraine, Pain and Others), By Route of Administration (Oral,
Intravenous, Topical, Others), By Source (In-house v/s Contract Manufacturing
Organizations), By Distribution Channel (Online v/s Offline), By End User
(Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities,
FY2026”, has
evaluated the future growth potential of India diclofenac sodium market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in India diclofenac sodium market.
Contact
Mr. Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel:
+1-646-360-1656
Email:
[email protected]